CA Patent

CA2475026A1 — A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders

Assigned to UCB SA · Expires 2001-06-07 · 25y expired

What this patent protects

A use of (S)-(-)-.alpha.-ethyl-2-oxo-1-pyrrolidineacetamide for the manufacture of a medicament for treatment of particular diseases and new pharmaceutical compositions comprising (S)-(-)-.alpha.-ethyl-2-oxo-1-pyrrolidineacetamide

USPTO Abstract

A use of (S)-(-)-.alpha.-ethyl-2-oxo-1-pyrrolidineacetamide for the manufacture of a medicament for treatment of particular diseases and new pharmaceutical compositions comprising (S)-(-)-.alpha.-ethyl-2-oxo-1-pyrrolidineacetamide

Drugs covered by this patent

Patent Metadata

Patent number
CA2475026A1
Jurisdiction
CA
Classification
—
Expires
2001-06-07
Drug substance claim
No
Drug product claim
No
Assignee
UCB SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.